Sohai, D. K., Keller, M. D., Hanley, P. J., Hoq, F., Kukadiya, D., Datar, A., Reynolds, E., Copertino, D. C., Lazarski, C., McCann, C. D., Tanna, J., Shibli, A., Lang, H., Zhang, A., Chansky, P. A., Motta, C., Huynh, T. T., Dwyer, B., Wilson, A., Lynch, R., Mota, T. M., Alberto, W. D. C., Brumme, Z. L., Kinloch, N. N., Cruz, C. R. Y., Ehui, L. M., Henn, S., Jones, R. B., Bollard, C. M. (2025). Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study. Nature Communications. https://doi.org/10.1038/s41467-025-59810-2